Consensus IDEXX Laboratories, Inc. Borsa Italiana

Stocks

1IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 08:25:47 31/08/2026 BST			5-day change	1st Jan Change
475.15 ^EUR	-0.41%		+0.72%	-17.91%

08-18	IDEXX Laboratories, Inc. - Analyst/Investor Day
08-11	IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment	MT

Evolution of the Average Target: IDEXX Laboratories, Inc.

Evolution of the Target Price: IDEXX Laboratories, Inc.

Changes in Analyst Recommendations: IDEXX Laboratories, Inc.

5ef1a32d36fcfe.DTvR6PkQ0V-U9QlmNeNalVUIusukF2hlZT1M3tIKMPM.SULnxY1C5G7Gm142V9UYoDpd-ZzxYz8pH0QorJ9IA5FuQp2LyFGaKO2yag~e9022157fe0b90f02545f4a7f550f63e

Analysts' recommendations: IDEXX Laboratories, Inc.

08-11	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
08-05	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
08-05	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
08-05	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
07-27	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
07-27	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
07-13	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
05-06	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
05-06	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
04-28	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
04-27	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
04-15	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
04-14	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
03-31	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
02-09	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT
02-05	Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating	MT
02-04	Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850	MT
02-03	Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830	MT
02-03	UBS Adjusts IDEXX Laboratories PT to $730 From $750	MT
02-03	Leerink Partners Adjusts Price Target on IDEXX Laboratories to $760 From $785	MT
02-03	BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830	MT
02-03	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700	MT
12-09	Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target	MT
11-10	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700	MT
11-04	UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating	MT